Moin Andrew Insider Trades

Insider Trading History

Track insider trading activity for Moin Andrew. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $8.51M 2,198,457 shares
Last Trade
Sep 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.39M 1,740,000 shares
$1.95
$3.87
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $817k 211,100 shares
Last Trade
Sep 29, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33.9k 17,400 shares
$1.95
$3.87
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $2.11k 211,100 shares
Last Trade
Sep 29, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$435 17,400 shares
$0.02
$0.01
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $22k 2,198,457 shares
Last Trade
Sep 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$43.5k 1,740,000 shares
$0.02
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $884k 228,500 shares
Last Trade
Jul 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.49M 571,250 shares
$2.61
$3.87
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $2.29k 228,500 shares
Last Trade
Jul 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.7k 571,250 shares
$0.03
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $0 0 shares
Last Trade
Nov 24, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$281k 31,269 shares
$9.00
$3.87
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $17.7M 4,584,571 shares
Last Trade
Nov 24, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$255k 28,380 shares
$9.00
$3.87
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $0 0 shares
Last Trade
Nov 24, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.81k 31,269 shares
$0.06
$0.01
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $45.8k 4,584,571 shares
Last Trade
Nov 24, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.65k 28,380 shares
$0.06
$0.01
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $133 13,269 shares
Last Trade
Nov 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$824 13,269 shares
$0.06
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $51.4k 13,269 shares
Last Trade
Nov 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$123k 13,269 shares
$9.30
$3.87
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $121k 31,269 shares
Last Trade
Nov 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$123k 13,269 shares
$9.30
$3.87
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $0 0 shares
Last Trade
Nov 13, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$123k 13,269 shares
$9.30
$3.87
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $313 31,269 shares
Last Trade
Nov 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$824 13,269 shares
$0.06
$0.01
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $0 0 shares
Last Trade
Nov 13, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$824 13,269 shares
$0.06
$0.01
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $521 52,115 shares
Last Trade
Nov 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.75k 44,230 shares
$0.06
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $202k 52,115 shares
Last Trade
Nov 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$429k 44,230 shares
$9.70
$3.87
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $0 0 shares
Last Trade
Oct 23, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.2k 16,269 shares
$0.07
$0.01
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $180 18,000 shares
Last Trade
Oct 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2k 16,269 shares
$0.07
$0.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up